ThirtyFiveBio is an early-stage drug discovery company that was established in 2021 by a team of experienced pharmaceutical industry professionals and biotech entrepreneurs.

Based in Oxford, UK, the company is founded upon a deep understanding of the biology of GPR35. We are currently engaged in a fully enabled drug discovery program to identify novel small-molecule modulators of GPR35

Biotechnology

Pharmaceutical

ThirtyFiveBio

James Westcott

Stuart Hughes

Lisa Shoesmith

Josselin Caradec

Andrea Nisbet

Mitul Patel

Shelley Cook

Management and Operations Team

Leadership Team

Teams at ThirtyFiveBio

Management and Operations Team

Leadership Team